James Wentworth
Corporate Officer/Principal bij TRANSGENE
Profiel
James Wentworth is currently the Chief Business Officer & Vice President at Transgene SA. Previously, he worked as the Director of Business Development & Strategy at Adaptimmune Ltd.
He completed his undergraduate and doctorate degrees at the University of Bristol and holds an MBA from the International Institute for Management Development.
Actieve functies van James Wentworth
| Bedrijven | Functie | Begin |
|---|---|---|
| TRANSGENE | Corporate Officer/Principal | 22-01-2024 |
Eerdere bekende functies van James Wentworth
| Bedrijven | Functie | Einde |
|---|---|---|
Adaptimmune Ltd.
 Adaptimmune Ltd. Medical/Nursing ServicesHealth Services Adaptimmune Ltd. develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases. It utilizes the T cell to target and destroy cancerous and infected cells by using affinity T cell receptor proteins as a means of strengthening patient T cell responses. The company was founded by Bent K. Jakobsen, James Julian Noble and Helena Katrina Tayton-Martin in 2008 and is headquartered in Oxford, the United Kingdom. | Corporate Officer/Principal | - |
Opleiding van James Wentworth
| University of Bristol | Doctorate Degree |
| International Institute for Management Development | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| TRANSGENE | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Adaptimmune Ltd.
Adaptimmune Ltd. Medical/Nursing ServicesHealth Services Adaptimmune Ltd. develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases. It utilizes the T cell to target and destroy cancerous and infected cells by using affinity T cell receptor proteins as a means of strengthening patient T cell responses. The company was founded by Bent K. Jakobsen, James Julian Noble and Helena Katrina Tayton-Martin in 2008 and is headquartered in Oxford, the United Kingdom. | Health Services |
